{"id":"complete-insulin-orders","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"This is not a pharmaceutical drug but rather a healthcare management program or protocol developed by HealthPartners Institute to standardize and improve insulin ordering practices. It likely provides clinical guidance on appropriate insulin selection, dosing, and administration to enhance glycemic control and patient safety in diabetes management.","oneSentence":"Complete Insulin Orders is a clinical decision support program that optimizes insulin prescribing and dosing in healthcare settings.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:30:55.176Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Clinical decision support for insulin therapy optimization"}]},"trialDetails":[{"nctId":"NCT03455985","phase":"NA","title":"Effectiveness of a Diabetes Focused Discharge Order Set Among Poorly Controlled Hospitalized Patients Transitioning to Glargine U300 Insulin","status":"TERMINATED","sponsor":"Ohio State University","startDate":"2018-05-01","conditions":"Diabetes Mellitus, Type 2, Patient Discharge, Blood Glucose, Low","enrollment":158},{"nctId":"NCT05610124","phase":"NA","title":"Postprandial Glycemia and Satiety of Meals With Potatoes, With and Without Protein","status":"UNKNOWN","sponsor":"University of Toronto","startDate":"2023-02-01","conditions":"Glycemic Control, Satiety Response, Appetite Regulation","enrollment":30},{"nctId":"NCT01184014","phase":"PHASE4","title":"Hospital Insulin Protocol Aims for Glucose Control in Corticosteroid-induced Hyperglycemia","status":"COMPLETED","sponsor":"HealthPartners Institute","startDate":"2010-08","conditions":"Hyperglycemia","enrollment":72}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["lantus","glargine","humalog","lispro"],"phase":"marketed","status":"active","brandName":"Complete Insulin Orders","genericName":"Complete Insulin Orders","companyName":"HealthPartners Institute","companyId":"healthpartners-institute","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Complete Insulin Orders is a clinical decision support program that optimizes insulin prescribing and dosing in healthcare settings. Used for Clinical decision support for insulin therapy optimization.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}